Dagmar Koethe

6.6k total citations · 1 hit paper
64 papers, 4.6k citations indexed

About

Dagmar Koethe is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dagmar Koethe has authored 64 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 19 papers in Psychiatry and Mental health and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dagmar Koethe's work include Cannabis and Cannabinoid Research (29 papers), Schizophrenia research and treatment (13 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Dagmar Koethe is often cited by papers focused on Cannabis and Cannabinoid Research (29 papers), Schizophrenia research and treatment (13 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Dagmar Koethe collaborates with scholars based in Germany, Australia and United Kingdom. Dagmar Koethe's co-authors include F. Markus Leweke, C.W. Gerth, Joachim Klosterkötter, Daniele Piomelli, Martin Hellmich, Daniela Schreiber, Carolin Hoyer, Franziska Pahlisch, Andrea Giuffrida and Laura Kranaster and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dagmar Koethe

62 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

2012 785 citations F. Markus Leweke, Daniele Piomelli et al. profile →

Peers

Countries citing papers authored by Dagmar Koethe

Since Specialization

Citations

This map shows the geographic impact of Dagmar Koethe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Koethe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Koethe more than expected).

Fields of papers citing papers by Dagmar Koethe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Koethe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Koethe. The network helps show where Dagmar Koethe may publish in the future.

Co-authorship network of co-authors of Dagmar Koethe

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Koethe. A scholar is included among the top collaborators of Dagmar Koethe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Koethe. Dagmar Koethe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroimmune-mediated neuropsychiatric syndromes: perspectives for standardised diagnostics and personalised care 2024 ·Elizabeth Scott, (unknown), Richard B. Banati, David A. Brown, Dagmar Koethe, F. Markus Leweke, Cathrin Rohleder, Ian B. Hickie	0
2	Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers 2024 ·SHILAP Revista de lepidopterología ·Timothy A. Couttas, (unknown), Franziska Pahlisch, (unknown), Juliane K. Mueller, (unknown), (unknown), (unknown), Anna Hoffmann, (unknown), O. Grimm, Frank Enning, Herta Flor, Andreas Meyer‐Lindenberg, Dagmar Koethe, Cathrin Rohleder, F. Markus Leweke	0
3	Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol 2024 ·Psychiatry Research ·(unknown), (unknown), Cathrin Rohleder, (unknown), Anna Hoffmann, Dagmar Koethe, F. Markus Leweke, Timothy A. Couttas	3
4	Double-blind, randomised placebo-controlled clinical trial of metformin as an adjunct to a sleep–wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and mood symptoms in youth with major mood syndromes: study protocol 2023 ·BMJ Open ·Chloe Wilson, Joanne S. Carpenter, Alissa Nichles, Natalia Zmicerevska, Yun Ju Christine Song, Catherine McHugh, (unknown), Samuel J Hockey, Jacob J. Crouse, Dagmar Koethe, Elizabeth Scott, Ian B. Hickie	1
5	Cross‐sectional and longitudinal associations between cardiometabolic measures and clinical stage in young people accessing early intervention mental health services 2023 ·Early Intervention in Psychiatry ·Chloe Wilson, Joanne S. Carpenter, Jacob J. Crouse, Shin Park, Dagmar Koethe, Elizabeth Scott, Ian B. Hickie	4
6	Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state 2023 ·Frontiers in Psychiatry ·Dagmar Koethe, Cathrin Rohleder, Lutz Kracht, F. Markus Leweke	4
7	Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N -Acylethanolamines by Liquid Chromatography–Tandem Mass Spectrometry 2022 ·Cannabis and Cannabinoid Research ·Timothy A. Couttas, (unknown), Franziska Pahlisch, (unknown), (unknown), Dagmar Koethe, Heike Endepols, Cathrin Rohleder, F. Markus Leweke	11
8	Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers 2021 ·Frontiers in Psychiatry ·Christian G. Bien, Cathrin Rohleder, Juliane K. Mueller, Corinna Bien, Dagmar Koethe, F. Markus Leweke	21
9	Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services 2020 ·BMJ Open ·Cathrin Rohleder, Yun Ju Christine Song, Jacob J. Crouse, Tracey A Davenport, Frank Iorfino, (unknown), Natalia Zmicerevska, Alissa Nichles, Joanne S. Carpenter, Ashleigh Tickell, Chloe Wilson, Shane Cross, Adam J. Guastella, Dagmar Koethe, F. Markus Leweke, Elizabeth Scott, Ian B. Hickie	7
10	Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans 2019 ·Current Opinion in Psychiatry ·Verity Chadwick, Cathrin Rohleder, Dagmar Koethe, F. Markus Leweke	51
11	Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages 2018 ·eLife ·Tineke Grent-‘t-Jong, Joachim Groß, Jozien Goense, Michael Wibral, Ruchika Gajwani, Andrew Gumley, Stephen M. Lawrie, Matthias Schwannauer, Frauke Schultze‐Lutter, Tobias Navarro Schröder, Dagmar Koethe, F. Markus Leweke, Wolf Singer, Peter J. Uhlhaas	121
12	Familial abnormalities of endocannabinoid signaling in schizophrenia 2018 ·The World Journal of Biological Psychiatry ·Dagmar Koethe, Franziska Pahlisch, Martin Hellmich, Cathrin Rohleder, Juliane K. Mueller, Andreas Meyer‐Lindenberg, E. Fuller Torrey, Daniele Piomelli, F. Markus Leweke	33
13	Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention 2018 ·CNS Drugs ·F. Markus Leweke, Juliane K. Mueller, Bettina Lange, Stefan Fritze, (unknown), Dagmar Koethe, Cathrin Rohleder	37
14	Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients 2018 ·European Archives of Psychiatry and Clinical Neuroscience ·Cathrin Rohleder, Dagmar Koethe, Stefan Fritze, (unknown), F. Markus Leweke, Dušan Hirjak	2
15	Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders 2013 ·European Archives of Psychiatry and Clinical Neuroscience ·(unknown), Frank Enning, Juliane K. Mueller, Jan Malte Bumb, Cathrin Rohleder, Thorsten Odorfer, Joachim Klosterkötter, Martin Hellmich, Dagmar Koethe, Christian Schmahl, Martin Bohus, F. Markus Leweke	69
16	The endocannabinoid system as a target for modelling psychosis 2009 ·Psychopharmacology ·Dagmar Koethe, Carolin Hoyer, F. Markus Leweke	35
17	The role of cannabis in cognitive functioning of patients with schizophrenia 2009 ·Psychopharmacology ·Thomas Schnell, Dagmar Koethe, Jörg Daumann, Euphrosyne Gouzoulis‐Mayfrank	75
18	Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression 2007 ·Journal of Neural Transmission ·Dagmar Koethe, Ida C. Llenos, (unknown), Carolin Hoyer, Ε. Fuller Torrey, F. Markus Leweke, Serge Weis	138
19	CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis 2007 ·PLoS ONE ·Jeffrey Huang, F. Markus Leweke, Tsz M. Tsang, Dagmar Koethe, Laura Kranaster, C.W. Gerth, Sonja Groß, Daniela Schreiber, Stephan Ruhrmann, Frauke Schultze‐Lutter, Joachim Klosterkötter, Elaine Holmes, Sabine Bahn	109
20	The endocannabinoid anandamide in CSF is related to the patterns of cannabis use in first-episode schizophrenia 2005 ·Biological Psychiatry ·Dagmar Koethe, (unknown), Daniela Schreiber, (unknown), S K Gross, (unknown), J. Klosterkoetter, Andrea Giuffrida, Daniele Piomelli, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact